Alcon Inc.'s strong growth, strategic acquisitions, and market leadership highlight its long-term potential. Read more on ALC ...

PRECISION7, a reusable one-week replacement contact lens, has been widely launched in the U.S. This product targets a $3.8 billion market segment where Alcon is under-indexed. Early feedback ...

Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients ...

In contact lenses, the company is successfully executing its strategy of investing in fast-growing market segments where it ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

GENEVA, April 02, 2025--Alcon Expands Leadership in IOL Innovation ... the first and only monthly replacement Water Gradient toric contact lens,1-3 delivering the same exceptionally comfortable ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on Alcon (ALC) to $112 from $108 on higher multiple, while keeping an Overweight ...

Alcon operates in two segments: vision care and surgical. Vision care made up 43% of fiscal 2023 total sales and comprises contact lenses and ocular health products. The U.S. contact lens market ...